Aclarubicin in the treatment of de-novo acute myelocytic leukaemia.
Labar
B
B
Department of Medicine, Clinical Hospital Center, Rebro, Zagreb, Yugoslavia.
Nemet
D
D
Minigo
H
H
Bogdanić
V
V
Jaksić
B
B
Malesević
M
M
Mrsić
M
M
D015250:Aclarubicin / Q000627:therapeutic use*; D000293:Adolescent; D000328:Adult; D016026:Bone Marrow Transplantation; D003131:Combined Modality Therapy; D003630:Daunorubicin / Q000627:therapeutic use; D005260:Female; D006801:Humans; D015470:Leukemia, Myeloid, Acute / Q000188:drug therapy* / Q000601:surgery; D008297:Male; D008875:Middle Aged; D016032:Randomized Controlled Trials as Topic
D015250:Aclarubicin; D003630:Daunorubicin